Logo image of OBE

OBSIDIAN ENERGY LTD (OBE) Stock Fundamental Analysis

USA - NYSEARCA:OBE - CA6744822033 - Common Stock

6.245 USD
-0.05 (-0.87%)
Last: 9/19/2025, 12:46:07 PM
Fundamental Rating

2

OBE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 210 industry peers in the Oil, Gas & Consumable Fuels industry. OBE has a bad profitability rating. Also its financial health evaluation is rather negative. OBE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year OBE has reported negative net income.
In the past year OBE had a positive cash flow from operations.
In multiple years OBE reported negative net income over the last 5 years.
In the past 5 years OBE always reported a positive cash flow from operatings.
OBE Yearly Net Income VS EBIT VS OCF VS FCFOBE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B

1.2 Ratios

OBE's Return On Assets of -11.86% is on the low side compared to the rest of the industry. OBE is outperformed by 85.24% of its industry peers.
With a Return On Equity value of -15.86%, OBE is not doing good in the industry: 76.19% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 7.74%, OBE is in the better half of the industry, outperforming 69.05% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for OBE is significantly below the industry average of 21.66%.
Industry RankSector Rank
ROA -11.86%
ROE -15.86%
ROIC 7.74%
ROA(3y)10.66%
ROA(5y)-3.82%
ROE(3y)14.48%
ROE(5y)-28.26%
ROIC(3y)8.82%
ROIC(5y)8.37%
OBE Yearly ROA, ROE, ROICOBE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150 -200

1.3 Margins

OBE has a Operating Margin (24.16%) which is in line with its industry peers.
In the last couple of years the Operating Margin of OBE has declined.
Looking at the Gross Margin, with a value of 69.68%, OBE is in the better half of the industry, outperforming 79.52% of the companies in the same industry.
OBE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 24.16%
PM (TTM) N/A
GM 69.68%
OM growth 3Y-12.26%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y2.34%
OBE Yearly Profit, Operating, Gross MarginsOBE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so OBE is destroying value.
The number of shares outstanding for OBE has been reduced compared to 1 year ago.
Compared to 5 years ago, OBE has more shares outstanding
OBE has a worse debt/assets ratio than last year.
OBE Yearly Shares OutstandingOBE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
OBE Yearly Total Debt VS Total AssetsOBE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

OBE has an Altman-Z score of 0.87. This is a bad value and indicates that OBE is not financially healthy and even has some risk of bankruptcy.
OBE has a Altman-Z score (0.87) which is comparable to the rest of the industry.
OBE has a debt to FCF ratio of 5.61. This is a neutral value as OBE would need 5.61 years to pay back of all of its debts.
OBE has a better Debt to FCF ratio (5.61) than 60.95% of its industry peers.
OBE has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
OBE has a better Debt to Equity ratio (0.13) than 73.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 5.61
Altman-Z 0.87
ROIC/WACC0.82
WACC9.4%
OBE Yearly LT Debt VS Equity VS FCFOBE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

OBE has a Current Ratio of 0.80. This is a bad value and indicates that OBE is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.80, OBE is doing worse than 67.14% of the companies in the same industry.
OBE has a Quick Ratio of 0.80. This is a bad value and indicates that OBE is not financially healthy enough and could expect problems in meeting its short term obligations.
OBE has a Quick ratio (0.80) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.8
OBE Yearly Current Assets VS Current LiabilitesOBE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2

3. Growth

3.1 Past

OBE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -310.93%.
Looking at the last year, OBE shows a small growth in Revenue. The Revenue has grown by 1.85% in the last year.
The Revenue has been growing by 13.38% on average over the past years. This is quite good.
EPS 1Y (TTM)-310.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-55.11%
Revenue 1Y (TTM)1.85%
Revenue growth 3Y17.6%
Revenue growth 5Y13.38%
Sales Q2Q%-39.34%

3.2 Future

The Earnings Per Share is expected to decrease by -77.09% on average over the next years. This is quite bad
The Revenue is expected to decrease by -11.43% on average over the next years. This is quite bad
EPS Next Y-183.51%
EPS Next 2Y-77.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-20.99%
Revenue Next 2Y-11.43%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
OBE Yearly Revenue VS EstimatesOBE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
OBE Yearly EPS VS EstimatesOBE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -50 -100 -150

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OBE. In the last year negative earnings were reported.
Also next year OBE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OBE Price Earnings VS Forward Price EarningsOBE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of OBE indicates a rather cheap valuation: OBE is cheaper than 96.19% of the companies listed in the same industry.
64.29% of the companies in the same industry are more expensive than OBE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.24
EV/EBITDA 2.06
OBE Per share dataOBE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

A cheap valuation may be justified as OBE's earnings are expected to decrease with -77.09% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-77.09%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

OBE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

OBSIDIAN ENERGY LTD

NYSEARCA:OBE (9/19/2025, 12:46:07 PM)

6.245

-0.05 (-0.87%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)07-30 2025-07-30
Earnings (Next)10-30 2025-10-30
Inst Owners27.43%
Inst Owner Change-0.88%
Ins Owners3.72%
Ins Owner ChangeN/A
Market Cap418.35M
Analysts72.5
Price Target7.18 (14.97%)
Short Float %7.9%
Short Ratio17.8
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.5%
PT rev (3m)1.58%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1471.43%
EPS NY rev (3m)-1471.43%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)3.8%
Revenue NY rev (3m)-8.18%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.82
P/FCF 14.24
P/OCF 1.53
P/B 0.41
P/tB 0.41
EV/EBITDA 2.06
EPS(TTM)-1.99
EYN/A
EPS(NY)-6.23
Fwd EYN/A
FCF(TTM)0.44
FCFY7.02%
OCF(TTM)4.09
OCFY65.42%
SpS7.63
BVpS15.08
TBVpS15.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.86%
ROE -15.86%
ROCE 10.29%
ROIC 7.74%
ROICexc 7.75%
ROICexgc 7.75%
OM 24.16%
PM (TTM) N/A
GM 69.68%
FCFM 5.75%
ROA(3y)10.66%
ROA(5y)-3.82%
ROE(3y)14.48%
ROE(5y)-28.26%
ROIC(3y)8.82%
ROIC(5y)8.37%
ROICexc(3y)8.83%
ROICexc(5y)8.4%
ROICexgc(3y)8.83%
ROICexgc(5y)8.4%
ROCE(3y)11.73%
ROCE(5y)11.13%
ROICexcg growth 3Y-18.98%
ROICexcg growth 5YN/A
ROICexc growth 3Y-18.98%
ROICexc growth 5YN/A
OM growth 3Y-12.26%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y2.34%
F-Score6
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 5.61
Debt/EBITDA 0.45
Cap/Depr 152.01%
Cap/Sales 47.79%
Interest Coverage 5.54
Cash Conversion 96.3%
Profit Quality N/A
Current Ratio 0.8
Quick Ratio 0.8
Altman-Z 0.87
F-Score6
WACC9.4%
ROIC/WACC0.82
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)47.68%
Cap/Sales(5y)38.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-310.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-55.11%
EPS Next Y-183.51%
EPS Next 2Y-77.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.85%
Revenue growth 3Y17.6%
Revenue growth 5Y13.38%
Sales Q2Q%-39.34%
Revenue Next Year-20.99%
Revenue Next 2Y-11.43%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1.67%
EBIT growth 3Y3.18%
EBIT growth 5YN/A
EBIT Next Year67.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-38.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2.68%
OCF growth 3Y22.12%
OCF growth 5Y36.28%